Company intelligence / Profile preview

CGT Global

Folsom, California, United Statescgt.global ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

CGT Global is a leading US-based provider of human primary cells, stem cells, bone marrow, cord blood, peripheral blood, and disease-state products. Their biospecimens are used globally in research and clinical trials supporting the development of cell and gene therapies. They operate GMP-certified labs and clinics across the US with a focus on accelerating access to advanced therapies by streamlining collection, processing, and delivery of high-quality biological materials for academic institutions, biotech/pharma companies, CROs/CDMOs.

Therapeutic areas: OncologyImmunologyOther
Modalities: Cell therapyGene therapyStem cell therapy
Industry: Chemicals & Materials

Partnerships

Cellex Cell Professionals (Germany): Partnership to expand global cell sourcing/manufacturing capabilities for cell/gene therapies.

Beyond the preview

Go deeper on CGT Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CGT Global.